Robert Califf, FDA commissioner (Michael Brochstein/Sipa USA/Sipa via AP Images)
March 31, 2022 04:02 PM EDTUpdated April 1, 06:53 AM
FDA+

FDA chief Rob Califf: The busi­ness of health is boom­ing but peo­ple's out­comes aren't im­prov­ing

Zachary Brennan

Senior Editor

While re­fer­ring to him­self as liv­ing in the prover­bial “over­time” of life at the age of 70, new­ly Sen­ate-con­firmed FDA chief Rob Califf said his …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

CBER's deputy di­rec­tor de­parts as staff shake­up con­tin­ues

Blue­bird bio to sell to in­vest­ment funds af­ter strug­gling to make mon­ey from gene ther­a­pies

Eli Lil­ly stock­piles $548M of oral weight loss drug ahead of launch

FDA ap­proves first drug to treat ul­tra-rare lipid stor­age dis­ease

Will CRISPR mat­ter?

sponsored

Trust­ed pro­tec­tion: Why the cur­rent meningo­coc­cal vac­ci­na­tion sched­ule shouldn’t change with­out strong ev­i­dence

A service from the Financial Times